Category Archives: Pradaxa

Featured Stories

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Some heart doctors are raising concerns about a new class of heart drugs that include Pradaxa. Recently, a number of doctors interviewed by Reuters said they were hesitant to prescribe Pradaxa, as well as another blood thinner called Xarelto, because of concerns regarding the risk of stroke, serious bleeding ...

Read More

Bronx Teenager Killed in Hit-and-Run, Second Teen Injured

A Port Jefferson Station man was killed on Wednesday in a single-vehicle crash on the Northern State Pkwy in Dix Hills west of Exit 42. He was driving a Nissan Altima.

Read More

Pradaxa®, Other New Blood Thinners Can Triple Bleeding Risks in ACS Patients, Study Finds

A study of new blood thinners, including Pradaxa®, has found that these novel drugs pose an elevated bleeding risk that cancels out their benefits in patients with Acute Coronary Syndrome (ACS).  According to a report from MedPage Today, the study … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Study Finds New Blood Thinner Hasn’t Had Much Effect on Treatment of Atrial Fibrillation

A new Pradaxa study conducted by U.S. researchers has found that Pradaxa hasn’t really changed the way doctors treat atrial fibrillation, its approved indication.  According to a report from the UPI, the same study also found that a growing number … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Study Sees Higher Bleeding, Clot Risk after Atrial Fibrillation Ablation

A study published in February reported that patients who took Pradaxa (dabigatran) following radiofrequency ablation to treat atrial fibrillation experienced more bleeding and blood clots compared to people who were treated with warfarin post-procedure.  The authors of the study, published … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Bleeding Lawsuits To Proceed “Expeditiously,” Federal Judge Promises

A total of 78 Pradaxa bleeding lawsuits are now pending in the multidistrict litigation in U.S. District Court, Southern District of Illinois.  According to a report from The Madison Record, U.S. District Judge David Herndon has scheduled the Pradaxa litigation’s … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa, Other Dangerous Drugs Make it to Market Thanks to Quick FDA Approvals

A new study has questioned the Food and Drug Adminstration’s (FDA) process for approving new prescription drugs, especially after the agency allowed a trio of products to reach the market without serious questions about their safety being answered, including the … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Pradaxa Bleeding Lawsuit MDL Established in District of Southern Illinois

Lawsuits alleging the maker of Pradaxa failed to adequately warning users of its association with life-threatening, uncontrolled bleeding have been consolidated in a multidistrict litigation in U.S. District Court, Southern District of Illinois.  All Pradaxa injury lawsuits filed in federal … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Bid to Dismiss Pradaxa Bleeding Lawsuits Rejected

A federal judge in Illinois has denied Boehringer Ingelheim Pharmaceuticals motion to dismiss Pradaxa bleeding lawsuits.  The decision by Judge David Herndon in U.S. District Court, Southern District of Illinois, comes as Pradaxa plaintiffs throughout the country wait to hear … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation.  According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

64 More Plavix Patients File Suit Over Bleeding Side Effects

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged |

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Some heart doctors are raising concerns about a new class of heart drugs that include Pradaxa.  Recently, a number of doctors interviewed by Reuters said they were hesitant to prescribe Pradaxa, as well as another blood thinner called Xarelto, because … Continue reading

Posted in Pharmaceuticals, Pradaxa |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.